Supplementary Guidelines On Good Manufacturing Practices For Heating .

1y ago
7 Views
1 Downloads
3.23 MB
76 Pages
Last View : 25d ago
Last Download : 3m ago
Upload by : Ronan Garica
Transcription

Working document QAS/15.639/Rev.1May 2016Draft document for comment12345SUPPLEMENTARY GUIDELINES ONGOOD MANUFACTURING PRACTICES FOR HEATING,VENTILATION AND AIR-CONDITIONING SYSTEMS FORNON-STERILE PHARMACEUTICAL DOSAGE FORMS6REVISED DRAFT FOR 3031323334353637383940(May 2016)Should you have any comments on the attached text, please send these to Dr S. Kopp, GroupLead, Medicines Quality Assurance, Technologies, Standards and Norms (kopps@who.int) witha copy to Ms Marie Gaspard (gaspardm@who.int) by 12 July 2016.Medicines Quality Assurance working documents will be sent out electronically only andwill also be placed on the Medicines website for comment under “Current projects”. If youdo not already receive our draft working documents please let us have your email address(to bonnyw@who.int) and we will add it to our electronic mailing list. World Health Organization 2016All rights reserved.This draft is intended for a restricted audience only, i.e. the individuals and organizations havingreceived this draft. The draft may not be reviewed, abstracted, quoted, reproduced, transmitted,distributed, translated or adapted, in part or in whole, in any form or by any means outside theseindividuals and organizations (including the organizations' concerned staff and memberorganizations) without the permission of the World Health Organization. The draft should not bedisplayed on any website.Please send any request for permission to:Dr Sabine Kopp, Group Lead, Medicines Quality Assurance, Technologies, Standards and Norms,Department of Essential Medicines and Health Products, World Health Organization, CH-1211Geneva 27, Switzerland. Fax: (41-22) 791 4730; email: kopps@who.intThe designations employed and the presentation of the material in this draft do not imply theexpression of any opinion whatsoever on the part of the World Health Organization concerning thelegal status of any country, territory, city or area or of its authorities, or concerning the delimitationof its frontiers or boundaries. Dotted lines on maps represent approximate border lines for whichthere may not yet be full agreement.The mention of specific companies or of certain manufacturers’ products does not imply that theyare endorsed or recommended by the World Health Organization in preference to others of a similarnature that are not mentioned. Errors and omissions excepted, the names of proprietary products aredistinguished by initial capital letters.All reasonable precautions have been taken by the World Health Organization to verify theinformation contained in this draft. However, the printed material is being distributed withoutwarranty of any kind, either expressed or implied. The responsibility for the interpretation and useof the material lies with the reader. In no event shall the World Health Organization be liable fordamages arising from its use.This draft does not necessarily represent the decisions or the stated policy of the World HealthOrganization.

Working document QAS/15.639/Rev.1page 241424344454647SCHEDULE FOR THE PROPOSED ADOPTION PROCESS OFDOCUMENT QAS/15.639SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURINGPRACTICES FOR HEATING, VENTILATION AND AIRCONDITIONING SYSTEMS FOR NON-STERILEPHARMACEUTICAL DOSAGE FORMS.PROPOSAL FOR REVISIONDiscussion of proposed need for revision in view of thecurrent trends in engineering and experience gainedduring the implementation of this guidance in inspectionduring informal consultation on data management,bioequivalence, GMP and medicines’ inspection29 June–1 July 2015Preparation of draft proposal for revision by Mr D.Smith, consultant to the Medicines Quality Assurancegroup and Prequalification Team (PQT)-Inspections,based on the feedback received during the meeting andfrom PQT-InspectionsJuly–August 2015Circulation of revised working document for publicconsultationSeptember 2015Consolidation of comments received and review offeedback10 October 2015Presentation to the fiftieth meeting of the WHO ExpertCommittee on Specifications for PharmaceuticalPreparations12–16 October 2015Consolidation of comments received and review offeedbackJanuary–March2016Discussion at the informal consultation on goodpractices for health products manufacture and inspection,Geneva,4–6 April 2016Preparation of revision by Mr D. Smith, based oncomments provided by Mr A. Kupferman and Dr A.J.Van Zyl, both participants at the above-mentionedconsultation.May 2016Circulation of revised working document for publicconsultationMay 2016

Working document QAS/15.639/Rev.1page 348495051Consolidation of comments received and review offeedbackAugust–September2016Presentation to the fifty-first meeting of the WHO ExpertCommittee on Specifications for PharmaceuticalPreparations17–21 October 2016Any other follow-up action as required

Working document QAS/15.639/Rev.1page 452BACKGROUND5354555657585960During the consultation on data management, bioequivalence, GMP andmedicines’ inspection held in 2015 the possible revision of the guidancefor (WHO Technical Report Series, No. 961, Annex 5, 2011) wasdiscussed with the inspectors. It was suggested that in light of the newdevelopments a draft for revision be prepared. This new proposal forrevision was drafted based on the feedback received, the new, currenttrends in engineering and the experience gained during the implementationof this guidance in inspection.6162At the same time, the opportunity was used to improve the graphic imagesand make them more readable in e-version as well as in print.63Summary of main 5868788Below is a list of the main changes that have been made to the WHO TechnicalReport Series, No. 961, 2011, Annex 5: Supplementary guidelines on goodmanufacturing practices for heating, ventilation and air-conditioning systems fornon-sterile pharmaceutical dosage forms.891. The Premises section has been moved towards the beginning of the documentdue to its important impact on HVAC designs. In addition the text has beenexpanded and a number of sample layouts have been included.2. The HVAC sections have been re-arranged into a more logical sequence.3. The Commissioning, Qualification and Validation (C, Q & V) section hasbeen aligned with the proposed revisions to the Supplementary GMPValidation TRS, No. 937, Annex 4 guidelines.4. Significant notes were added under the new Supplementary notes on testprocedures section.5. The Maintenance section has been separated out of the C, Q & V section.6. All the diagrams have been revised (mainly to achieve better clarity).7. Throughout the document additional notes have been added and text revisedto provide better understanding and avoid ambiguity.

Working document QAS/15.639/Rev.1page ope of documentGlossaryPremisesDesign of HVAC systems and components5.1General5.2Air distribution5.3Recirculation system5.4Full fresh-air systems5.5Additional system components6.Protection6.1Products and personnel6.2Air filtration and air patterns6.3Unidirectional airflow6.4Infiltration6.5Cross-contamination and contamination6.6Pressure differential concept (high pressure differential,low airflow)6.7Physical barrier concept6.8Temperature and relative humidity7.Dust control8.Protection of the environment8.1General8.2Dust in exhaust air8.3Vapour and fume removal9.Commissioning, qualification and ion9.4Supplementary notes on test procedures9.4.1 General9.4.2 Airflow measurements9.4.3 Non-variable air particle counts9.4.4 HEPA filter integrity tests10.MaintenanceReferencesFurther reading

Working document QAS/15.639/Rev.1page ting, ventilation and air-conditioning (HVAC) play an important role inensuring the manufacture of quality pharmaceutical products. A well designedHVAC system will also provide comfortable conditions for operators.These guidelines mainly focus on recommendations for systems formanufacturers of non-sterile dosage forms, and include tablets, capsules,powders, liquids, creams, ointments, etc. The HVAC design principlescontained in the guidelines may be applied to other dosage forms.HVAC system design influences architectural layouts with regard to itemssuch as airlock positions, doorways and lobbies. The architectural componentshave an effect on room pressure, differential cascades and crosscontamination control. The prevention of contamination and crosscontamination is an essential design consideration of the HVAC system. Inview of these critical aspects, the design of the HVAC system should beconsidered at the concept design stage of a pharmaceutical manufacturingplant.Temperature, relative humidity and ventilation should be appropriate andshould not adversely affect the quality of pharmaceutical products duringtheir manufacture and storage, or the accurate functioning of equipment.This document aims to give guidance to pharmaceutical manufacturersand inspectors of pharmaceutical manufacturing facilities on the design,installation, qualification and maintenance of the HVAC systems.These guidelines are intended to complement those provided in Goodmanufacturing practices for pharmaceutical products (1) and should be readin conjunction with the parent guide. The additional standards addressed bythis guide should, therefore, be considered supplementary to the generalrequirements set out in the main principles guide (WHO Technical ReportSeries, No. 961, Annex 3)2.SCOPE OF DOCUMENTThese guidelines focus primarily on the design and good manufacturingpractices (GMP) requirements for HVAC systems for facilities for themanufacture of solid dosage forms. Most of the system design principlesfor facilities manufacturing solid dosage forms also apply to facilitiesmanufacturing other dosage forms (such as liquids, cream, ointments) andother classes of products including biological products, herbal medicines,complementary medicines and finishing process steps for APIs.Non-sterile forms typically include:

Working document QAS/15.639/Rev.1page 208209210211212213214 products with low water activity (less subject to microbialcontamination), e.g. oral solid dosage forms, suppositories;products with high water activity (more subject to microbialcontamination, depending on the formulation), e.g. liquids,drops, syrups, ointments and creams.Additional specific requirements apply for air-handling systems ofpharmaceutical sterile products and hazardous products. Guidelines forhazardous, sterile and biological product facilities are covered in separateWHO guidelines (WHO Technical Report Series, No. 957, Annex 3; WHOTechnical Report Series, No. 961, Annex 6; and working documentWHO/BS/2015.2253, intended to replace WHO Technical Report Series,No. 822, Annex 1, 1992, respectively).These guidelines are not intended to be prescriptive in specifying requirementsand design parameters. There are many parameters affecting a clean areacondition and it is, therefore, difficult to lay down the specific requirementsfor one particular parameter in isolation.Many pharmaceutical manufacturers have their own engineering design andqualification standards, and requirements may vary from one manufacturerto the next. Design parameters and user requirements should, therefore, beset realistically for each project, with a view to creating a cost-effectivedesign, yet still complying with all regulatory standards and ensuring thatproduct quality and safety are not compromised. The three primary aspectsaddressed in this guideline are the roles that the HVAC system plays inproduct protection, personnel protection and environmental protection(Figure 1).Cognizance should be taken of the products to be manufactured whenestablishing system design parameters. A facility manufacturing multipledifferent products may have more stringent design parameters with respectto cross-contamination control, compared with a single product facility.Risk assessment studies should be an integral part of the facility design andimplementation, from the user requirement specification stage rightthrough to validation, as indicated in the diagram below (Figure 2).Validation protocols and criteria should be justified by links to a writtenrisk assessment.

Working document QAS/15.639/Rev.1page 8215216217Figure 1. The guidelines address the various system criteria according tothe sequence set out in this diagramGMP PROTECTIONPROTECTION OFEXTERNALENVIRONMENTContamination(Product & Staff)Prevent Contactwith DustAvoid DustDischargeProtect fromProductContaminationPrevent Contactwith FumesAvoid FumeDischargeCorrect Temperature& HumidityAcceptable ComfortConditionsAvoid EffluentDischarge SYSTEMSSYSTEM VALIDATION218219

Working document QAS/15.639/Rev.1page 9220221Figure 2. GMP compliance sequence KRISKASSESSMENTASSESSMENTSTUDIESSTUDIESMPHVAC llations EMENTSPECIFICATIONCEMPL222C OM PL I A NGM PPL I A NC EGMP

Working document QAS/15.639/Rev.1page 72582592602612622632642652662672682693.GLOSSARYThe definitions given below apply to terms used in these guidelines. Theymay have different meanings in other contexts.acceptance criteria. Measurable terms under which a test resultwill be considered acceptable.action limit. The action limit is reached when the acceptancecriteria of a critical parameter have been exceeded. Results outside theselimits will require specified action and investigation.air changes per hour. The volume of air supplied to a room, in m3/hr,divided by the room volume, in m3.air-handling unit. The air-handling unit serves to condition the airand provide the required air movement within a facility.airflow protection booth. A booth or chamber, typically forpurposes of carrying out sampling or weighing, in order to provide productcontainment and operator protection.airlock. An enclosed space with two or more doors, which isinterposed between two or more rooms, e.g. of differing classes ofcleanliness, for the purpose of controlling the airflow between those roomswhen they need to be entered. An airlock is designed for and used byeither people or goods (personnel airlock (PAL); material airlock (MAL)).alert limit. The alert limit is reached when the normal operatingrange of a critical parameter has been exceeded, indicating that correctivemeasures may need to be taken to prevent the action limit being reached.as-built. Condition where the installation is complete with allservices connected and functioning but with no production equipment,materials or personnel present.at-rest. Condition where the installation is complete with equipmentinstalled and operating in a manner agreed upon by the customer andsupplier, but with no personnel present.central air-conditioning unit (see air-handling unit)change control. A formal system by which qualified representativesof appropriate disciplines review proposed or actual changes that mightaffect a validated status. The intent is to determine the need for action that

Working document QAS/15.639/Rev.1page 11270would ensure that the system is maintained in a validated 02303304305306307308309310311312313clean area (cleanroom). An area (or room or zone) with definedenvironmental control of particulate and microbial contamination,constructed and used in such a way as to reduce the introduction, generationand retention of contaminants within the area.clean-up (see recovery)closed system. A system where the product or material is notexposed to the manufacturing environment.commissioning. Commissioning is the documented process ofverifying that the equipment and systems are installed according tospecifications, placing the equipment into active service and verifying itsproper action. Commissioning takes place at the conclusion of projectconstruction but prior to validation.containment. A process or device to contain product, dust orcontaminants in one zone, preventing it from escaping to another zone.contamination. The undesired introduction of impurities of achemical or microbial nature, or of foreign matter, into or on to a startingmaterial or intermediate, during production, sampling, packaging orrepackaging, storage or transport.controlled area (classified area). An area within the facility inwhich specific environmental parameters, conditions and procedures aredefined, controlled and monitored to prevent degradation or crosscontamination of the product.controlled not classified. An area where some environmentalconditions are controlled (such as temperature), but the area has nocleanroom classification.critical parameter or component. A processing parameter (such astemperature or relative humidity) that affects the quality of a product, or acomponent that may have a direct impact on the quality of the product.critical quality attribute. A physical, chemical, biological ormicrobiological property or characteristic that should be within anappropriate limit, range or distribution to ensure the desired product quality.cross-contamination. Contamination of a starting material,intermediate product or finished product with another starting material or

Working document QAS/15.639/Rev.1page 6347348349350351352353354355356357product during production.cross-over-bench. Cross-over or step-over bench in change room todemarcate the barrier between different garment change procedures.design condition. Design condition relates to the specified range oraccuracy of a controlled variable used by the designer as a basis fordetermining the performance requirements of an engineered system.design qualification. Design qualification is the documented checkof planning documents and technical specifications for design conformitywith the process, manufacturing, good manufacturing practices andregulatory requirements.differential pressure. The difference in pressure between twopoints such as the pressure difference between an enclosed space and anindependent reference point, or the pressure difference between twoenclosed spaces.direct impact system. A system that is expected to have a directimpact on product quality. These systems are designed and commissionedin line with good engineering practice and, in addition, are subject toqualification practices.exfiltration. Exfiltration is the egress of air from a controlled area toan external zone.extract air. Air leaving a space, which could be either return air orexhaust air. Return air means that the air is returned to the air-handling unitand exhaust air means that the air is vented to atmosphere.facility. The built environment within which the clean area installationand associated controlled environments operate together with their supportinginfrastructure.good engineering practice. Established engineering methods andstandards that are applied throughout the project life cycle to deliverappropriate, cost-effective solutions.hazardous substance or product. A product or substance that maypresent a substantial risk of injury to health or to the environment.HEPA filter. High efficiency particulate air filter.

Working document QAS/15.639/Rev.1page 0391392393394395396397398399400401HVAC. Heating, ventilation and air-conditioning. Also referred toas Environmental control systems.indirect impact system. This is a system that is not expected tohave a direct impact on product quality, but typically will support a directimpact system. These systems are designed and commissioned according togood engineering practice only.infiltration. Infiltration is the ingress of air from an external zoneinto a controlled area.installation qualification. Installation qualification is documentedverification that the premises, HVAC system, supporting utilities andequipment have been built and installed in compliance with their approveddesign specification.ISO 14644. The International Standards Organization has developeda set of standards for the classification and testing of cleanrooms. Thestandard comprises 12 separate parts. Where ISO 14644 is referenced itimplies the latest revision.NLT. Not less than.NMT. Not more than.no-impact system. This is a system that will not have any impact,either directly or indirectly, on product quality. These systems are designedand commissioned according to good engineering practice only.non-critical parameter or component. A processing parameter orcomponent within a system where the operation, contact, data control, alarmor failure will have an indirect impact or no impact on the quality of theproduct.normal operating range. The range that the manufacturer selects asthe acceptable values for a parameter during normal operations. This rangemust be within the operating range.OOS. Out of specification. In relation to HVAC systems this couldrefer to any of the environmental conditions being OOS, i.e. falling outside ofalert or action limits.operating limits. The minimum and/or maximum values that willensure that product and safety requirements are met.

Working document QAS/15.639/Rev.1page 4435436437438439440441442443444445446operating range. Operating range is the range of validated criticalparameters within which acceptable products can be manufactured.operational condition. This condition relates to carrying out roomclassification tests with the normal production process with equipment inoperation and the normal staff present in the specific room.operational qualification. Operational qualification is the documentaryevidence to verify that the equipment operates in accordance with its designspecifications in its normal operating range and performs as intended throughoutall anticipated operating ranges.oral solid dosage. Usually refers to an oral solid dosage plant thatmanufactures medicinal products such as tablets, capsules and powders tobe taken orally.pass-through-hatch or pass box. A cabinet with two or more doorsfor passing equipment, material or product, whilst maintaining the pressurecascade and segregation between two controlled zones. A passive passthrough-hatch (PTH) has no air supply or extract. A dynamic PTH has anair supply into the chamber.performance qualification. Performance qualification is thedocumented verification that the process and/or the total process related to thesystem performs as intended throughout all anticipated operating ranges.point extraction. Air extraction to remove dust with the extractionpoint located as close as possible to the source of the dust.pressure cascade. A process whereby air flows from one area,which is maintained at a higher pressure, to another area maintained at alower pressure.qualification. Qualification is the planning, carrying out andrecording of tests on equipment and a system, which forms part of thevalidated process, to demonstrate that it will perform as intended.quality critical process parameter. A process parameter whichcould have an impact on the critical quality attribute.recovery. Room recovery or clean-up tests are performed to determinewhether the installation is capable of returning to a specified cleanliness levelwithin a finite time, after being exposed briefly to a source of airborneparticulate challenge.

Working document QAS/15.639/Rev.1page 9480481482483484485486487488489490relative humidity. The ratio of the actual water vapour pressure ofthe air to the saturated water vapour pressure of the air at the sametemperature expressed as a percentage. More simply put, it is the ratioof the mass of moisture in the air, relative to the mass at 100% moisturesaturation, at a given temperature.standard operating procedure. An authorized written procedure,giving instructions for performing operations, not necessarily specific to agiven product or material, but of a more general nature (e.g. operation ofequipment, maintenance and cleaning, validation, cleaning of premises andenvironmental control, sampling and inspection). Certain standard operatingprocedures may be used to supplement product-specific master and batchproduction documentation.turbulent flow. Turbulent flow, or non-unidirectional airflow, is airdistribution that is introduced into the controlled space and then mixes withroom air by means of induction.unidirectional airflow. Unidirectional airflow is a rectified airflowover the entire cross-sectional area of a clean zone with a steady velocityand approximately parallel streamlines (see also turbulent flow). (Modernstandards no longer refer to laminar flow, but have adopted the termunidirectional airflow.)validation. The documented act of proving that any procedure,process, equipment, material, activity or system actually leads to theexpected results.validation master plan. Validation master plan is a high-leveldocument which establishes an umbrella validation plan for the entireproject and is used as guidance by the project team for resource andtechnical planning (also referred to as master qualification plan).4.PREMISES4.1.There is a close relationship between architectural design andHVAC design, as they both have an impact on the functionality of theother. HVAC system design influences architectural layouts with regard toitems such as airlock positions, doorways and lobbies. The architecturallayouts and building components have an effect on room pressuredifferential cascades and cross-contamination control. The prevention ofcontamination and cross-contamination is an essential design consideration

Working document QAS/15.639/Rev.1page 3524525526527528529530531of the HVAC system. In view of these critical aspects, the design of theHVAC system should be considered at the concept design stage of apharmaceutical manufacturing plant, and the design should be closelycoordinated with the architectural designers. The above designconsiderations should also be applicable to facility upgrades or theretrofitting of facilities.4.2.As the efficient operation of the air-handling system and cleanlinesslevels attained are reliant on the correct building layout and buildingfinishes, the following items should be considered.4.2.1. Adequate airlocks, such as personnel airlocks (PAL) and/or materialairlocks (MAL), pass-through hatches (PTH), change rooms and passagesshould be provided to limit air transfer between different cleanliness zones,and may be provided to limit cross-contamination within the samecleanliness zone. These should have supply and extract air systems asappropriate.4.2.2. Areas such as airlocks, change rooms and passages should bedesigned so that the required pressure cascades can be achieved.4.2.3. Detailed diagrams depicting pressure cascades, air flow directionsand flow routes for personnel and materials should be prepared andmaintained.4.2.4. Where possible, personnel and materials should not move from ahigher cleanliness zone to a lower cleanliness zone and back to a highercleanliness zone (if moving from a lower cleanliness zone to a highercleanliness zone, changing/decontamination procedures should befollowed).4.2.5. The final change room should be the same good manufacturingpractices (GMP) classification grade (at rest) as the area into which it leads.4.2.6. Door gaps around the door perimeter have a marked impact on thepressure differential across the doorway. The fit of the doors should beagreed upon between the architect and the HVAC designer to ensure thatthe correct leakages are allowed for. Likewise the maintenance of doors isa critical factor in room pressure control (a poorly fitting door can severelycompromise a room pressure differential).

Working document QAS/15.639/Rev.1page 5485495505515525535545554.2.7. Where the opening and closing of airlock doors could lead to crosscontamination, these airlock doors should not be opened simultaneously.An interlocking system and/or a visual and/or audible warning systemshould be operated to prevent the opening of more than one door at a time.556557558559560561Room pressure differentials could be lower or higher depending on thespecific design and operations. The purpose of a pressure differential is toenhance the separation between areas with different levels of cleanlinessand also to provide containment to prevent cross-contamination. Wherethere is no difference in cleanliness level, and no potential for crosscontamination, a zero pressure differential can be applied.5624.2.8. Doors should be carefully designed to avoid un-cleanable recesses.Swing doors should open to the high-pressure side and be provided withself-closers. Exceptions are permitted based on site environmental, fire,health and safety containment requirements. Cognizance should be taken ofpossible room pressure changes due to fan failure and the impact on ease ofopening doors for escape purposes.4.2.9. The choice of building finishes and materials also has an impact onair conditioning performance

Working document QAS/15.639/Rev.1 May 2016 Draft document for comment Draft document for comment 1 SUPPLEMENTARY GUIDELINES ON 2 GOOD MANUFACTURING PRACTICES FOR HEATING, 3 VENTILATION AND AIR-CONDITIONING SYSTEMS FOR 4 NON-STERILE PHARMACEUTICAL DOSAGE FORMS (May5 2016) 6 REVISED DRAFT FOR COMMENT 7 Should you have any comments on the attached text, please send these to Dr S. Kopp, Group

Related Documents:

Good morning, good morning Good afternoon Good evening, good evening Good night, good night Nice to meet you Nice to meet you, too. Goodbye, goodbye. See you. (repite x2) See you later! The Greetings Song (Saludos) Good morning, good morning Good afternoon Good evening, good evening Good night, go

Guidelines Heuristics (rules that are generally true) –have been developed for various manufacturing technologies. Some DFM guidelines –Guidelines for machining –Guidelines for assembly –Guidelines for injection molding –Guidelines for sheet metal processing –Guidelines for sheet die forming –Guidelines for casting

Objectives of the ISSA Guidelines on Good Governance 10 Definition of Good Governance 11 Governance Framework for Social Security Institutions 13 Structure of the ISSA Guidelines on Good Governance 15 Acknowledgements 16 A. Good Governance Guidelines for the Board and Management 17 A.1. Principles and Guidelines for the Board 18 A.1.1.

5.3 Supplementary Nutrition Programme: Supplementary nutrition is given to the beneficiaries under ICDS programme with an objective to provide 500 calories of energy and 12-15 grams of protein, as a supplement to their normal intake as envisaged in the scheme guidelines. Supplementary nutrition is given for 300 days in a year at a cost of Rs .

FDFPH1001A Follow work procedures to maintain Good Manufacturing Practice 3.5 . Manufacturing Skills Australia Manufacturing Industry Skills Council PMA Chemical, Hydrocarbons and Refining Training Package Business Case Page 8 of 32 FDFPH2001A Apply Good Manufacturing Practice procedures

Songs & Chants: Good Morning, Good Evening Speaking and Listening Good Morning, Good Evening The sun comes up, Good morning! The sun comes up, Good morning! The sun comes up, Good morning! Wake up! Get out of bed! The sun goes down, Good evening! The sun goes down, Good evening! The sun goes

of compliance of OTC drug products to 21 CFR Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General and 21 CFR Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals, a

AutoCAD 2000, 2000i & 2002 System Variables Highlighted numbers are preferred or standard Variables pertain to all versions except where noted (200XX) System Variable Command(s) affected _PKSER Environment (Read-only) Type: Integer Saved in: Registry Returns the serial number assigned to AutoCAD ACADLSPASDOC TOOLS/OPTIONS Type: Integer Saved in: Registry Initial value: 0 Controls whether .